ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dissecting the ferroptosis-related prognostic biomarker and immune microenvironment of driver gene-negative lung cancer

Zhou, Rui; Ma, Hao-Chuan; Liu, Yi-Hong; Chen, Xian; Chang, Xue-Song; Chen, Ya-Dong; Liu, Li-Rong; Li, Yong; Zhu, Yan-Juan*; Zhang, Hai-Bo*广东省人民医院; 广州中医药大学
Experimental Biology and Medicine2022-8DOI: 10.1177/15353702221102872
1被引8阅读
引用收藏
分享

摘要

Despite significant advances in targeted and immune therapy for non-small cell lung cancer (NSCLC), effective therapies for wild-type epidermal growth factor receptor/anaplastic lymphoma kinase (EGFR/ALK(WT)) with low expression of programmed death ligand-1 (PD-L1) NSCLC remain elusive. Numerous studies have shown that ferroptosis plays an essential role in antitumor activity. To identify the molecular regulation patterns associated with ferroptosis, 351 EGFR/ALK(WT) NSCLC samples with low-level PD-L1 were extracted from The Cancer Genome Atlas (TCGA) and clustered using the k-means clustering technique. The two clusters associated with ferroptosis showed significantly different prognoses. In total, 169 differential expression genes (DEGs) were identified. Cluster differential analysis revealed that Cluster 1 had a significantly poorer overall survival (OS) and was associated with more negative immune regulation. In addition, TCGA samples were randomly assigned in a 7:3 ratio to a training group or testing group. A signature of eight genes associated with ferroptosis was established in the training cohort using DEGs and validated in the test cohort and three independent cohorts (GSE72049, GSE41271, and GSE50081). The 5-year area under the curve (AUC) was 0.713, which was significantly higher than that of other predictors, including TNM stage and age. Furthermore, the risk score was associated with immune function, immune infiltration, and immunotherapy response, with high-risk patients having a worse prognosis, an immune-suppressing phenotype, and a poor response to immune checkpoint inhibitors. This study aims to contribute to our understanding of the biological role of ferroptosis in EGFR/ALK(WT) NSCLC with low-level PD-L1, laying the groundwork for the development of novel therapeutic strategies.

学科与关键词

关键词
FerroptosisEGFRALK (WT)low PD-L1 expressionNSCLCprognosisimmune microenvironment
相关
加载中…
  • Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer
    Zhang, Heng-Chun; Deng, Shen-Hui; Pi, Ya-Nan; Guo, Jun-Nan; Xi, Hua; Shi, Xin; Yang, Xue-Fei; Zhang, Bo-Miao; Xue, Wei-Nan; Cui, Bin-Bin*; Liu, Yan-Long*Frontiers in Immunology, 2022, 13: 855849.被引 15
  • Combination Analysis of Ferroptosis and Immune Status Predicts Patients Survival in Breast Invasive Ductal Carcinoma
    Yang, Yang; Luo, Dankun; Gao, Wenqi; Wang, Qiang; Yao, Wenchao; Xue, Dongbo*; Ma, Biao*Biomolecules, 2023, 13(1): 147.
  • Construction of a Prognostic Model in Lung Adenocarcinoma Based on Ferroptosis-Related Genes
    Liang, Min*; Chen, Mafeng; Zhong, Yinghua; Singh, Shivank; Singh, ShantanuFrontiers in Genetics, 2021, 12: 739520.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Experimental Biology and Medicine
发表日期
2022-08
卷期
第 247 卷, 第 16 期
页码
1447-1465
DOI
10.1177/15353702221102872
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Science and Technology Planning Project of Guangdong Province [2017B030314166]; 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong KongMacau Joint Lab) [2020B1212030006]

作者

  • Z

    Zhou, Rui (第一作者)

    2 · guangzhou univ chinese med

  • M

    Ma, Hao-Chuan

    2 · guangzhou univ chinese med

查看全部 10 位作者收起作者
  • L

    Liu, Yi-Hong

    2 · guangdong prov hosp · guangzhou univ chinese med

  • C

    Chen, Xian

    2 · guangdong prov hosp · guangzhou univ chinese med

  • C

    Chang, Xue-Song

    2 · guangdong prov hosp · guangzhou univ chinese med

  • C

    Chen, Ya-Dong

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Liu, Li-Rong

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Li, Yong

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zhu, Yan-Juan (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zhang, Hai-Bo (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417